• where experts go to learn about FDA
  • Hyman Phelps McNamara

    • FDA Prevails in Generic COZAAR/HYZAAR 180-Day Exclusivity Forfeiture LitigationAugust 3rd, 2009

      By Kurt R. Karst –       Judge Rosemary M. Collyer of the U.S. District Court for the District of Columbia ruled in a 27-page opinion issued last Friday that the 180-day exclusivity forfeiture patent information withdrawal provision at FDC Act § 505(j)(5)(D)(i)(I)(bb)(CC) is not ambiguous and …

    • House Energy & Commerce Committee Reports Health Care Reform Bill with FOB and “Pay-for-Delay” ProvisionsAugust 2nd, 2009

      By Kurt R. Karst –       Last Friday, the House Energy and Commerce Committee favorably reported its version of “America’s Affordable Health Choices Act” (H.R. 3200) by a 31-28 vote after adopting several amendments.  A copy of the bill and amendments are available here.  Importantly, the …

    • Senate Committee Asks: CME – Higher Learning or Higher Earning?August 2nd, 2009

      By Carrie S. Martin – Last Wednesday, the Senate Special Committee on Aging held a hearing to discuss the conflicts of interest presented by the funding of continuing medical education (“CME”) by pharmaceutical and medical device companies.  Lewis Morris, Chief Counsel to the Office of …

    • Anne Northrup to be Nominated as CPSC CommissionerJuly 31st, 2009

      Yesterday, President Obama announced that he intends to nominate Anne Northrup as a Commissioner of the Consumer Product Safety Commission.  Anne Northrup was a Congresswoman from Kentucky from 1997-2006.  As we previously reported, earlier this month, Inez Moore Tenenbaum was sworn in as the ninth …

    • House Passes Food Safety Enhancement Act of 2009July 30th, 2009

      By Ricardo Carvajal – The U.S. House of Representatives has passed the Food Safety Enhancement Act of 2009, which would substantially strengthen FDA’s regulatory authority over foods.  The bill would grant FDA mandatory recall authority, expanded access to records, stronger seizure and administrative detention authorities, …

    • FTC Extends Deadline for Red Flags RuleJuly 29th, 2009

      By William T. Koustas –       Today, the FTC announced that it is delaying enforcement of the controversial Red Flags Rule (“the Rule”) until November 1, 2009.  The FTC press release states that it is extending the August 1, 2009 deadline, previously discussed in this blog, …

    • False Advertising Claim under Lanham Act Not Precluded or Barred by the FDC ActJuly 28th, 2009

      By Cassandra A. Soltis – In Pom Wonderful LLC v. Ocean Spray Cranberries, Inc., 2009 WL 2151355 (C.D. Cal. 2009), the U.S. District Court for the Central District of California determined that Pom Wonderful LLC’s (Pom’s) false advertising claim against Ocean Spray Cranberries, Inc. (Ocean …

    • FDA Finalizes Authorized Generics Reporting Rule; Electronic Submissions Will be Permitted and Eventually RequiredJuly 27th, 2009

      By Kurt R. Karst –       On July 28, 2009, FDA will publish a final rule amending the Agency’s regulations requiring that NDA holders submit in annual reports certain information to the Agency concerning authorized generics.  The regulations, which were first proposed in September 2008 – …

    • So What Does “Reasonable Probability of Serious Adverse Health Consequences or Death” Really Mean?July 24th, 2009

      By Ricardo Carvajal –       On July 23, FDA held the first of three public workshops to explain the Reportable Food Registry requirements that will take effect on September 8, 2009.  One thing was made clear: the agency has no plans to offer a definition of …

    • Two Synthes Inc. Execs Enter Guilty PleasJuly 22nd, 2009

      By Carmelina G. Allis – We previously reported that Synthes, Inc., Norian Corporation, and four of Synthes’s executives had been charged by the United States government for allegedly violating several provisions of Titles 18 and 21 of the United States Code.  The defendants allegedly conducted clinical …

    • United States v. Farinella: Vindicated on Appeal – It Does HappenJuly 21st, 2009

      Hyman, Phelps & McNamara’s John R. Fleder has written an article in the July/August 2009 edition of the Food and Drug Law Institute’s Update Magazine.  The article is entitled: “Vindicated on Appeal – It Does Happen.”  The article discusses a recent ruling in United States …

    • First FDA-Approved REMS for an OpioidJuly 20th, 2009

      By William T. Koustas – Last week, FDA announced the approval of Onsolis (fentanyl buccal soluble film) with a substantial Risk Evaluation and Mitigation Strategy ("REMS"), as well as a boxed warning.  Onsolis is a potent opioid that is administered through the mucous membranes of …

    • Senate Passes Bill Further Amending the CMEA (Our 600th FDA Law Blog Post!)July 19th, 2009

      By John A. Gilbert & Larry K. Houck – The Senate recently passed S. 256 which places additional requirements on retailers that sell ephedrine and pseudoephedrine.  The bill, known as the “Combat Methamphetamine Enhancement Act of 2009,” was referred to the House (H.R. 2923), which …

    • IFT Publishes Expert Report on Making Decisions About the Risks of Chemicals in Foods with Limited Scientific InformationJuly 17th, 2009

      By Ricardo Carvajal – The Institute of Food Technologists (“IFT”) has published an expert report that addresses the challenge of responding to food contamination events in the face of limited scientific information.  The report describes the U.S. legal framework that governs substances intentionally or inadvertently …

    • CIFOR Publishes Guidelines for Foodborne Disease Outbreak ResponseJuly 17th, 2009

      By Ricardo Carvajal – The Council to Improve Foodborne Outbreak Response (“CIFOR”) has published guidelines intended to help local, state and federal agencies improve their response to foodborne disease outbreaks. The guidelines address planning and preparation, surveillance and outbreak detection, investigation of clusters and outbreaks, …